Psychedelic Medicine Coalition
Working in Washington D.C. and nationwide to pave the way for adoption and acceptance of psychedelic medicine

WATCH:

PMC CEO featured on the Today Show
Check out the segment here

From Local Roots to National Reach

Psychedelic Medicine Coalition (PMC) is a nonpartisan nonprofit with roots in Washington, working nationwide to pave the way for safe, effective psychedelic medicines to enter mainstream healthcare. We work closely with businesses, clinicians, lawmakers, and agencies to educate about and advocate for the advancement of psychedelic medicine.

Our Initiatives

Strategic Partnerships
for Education
Together with our partners, we work to educate lawmakers, regulators, healthcare providers, patients and caregivers about new research and advances in psychedelic medicine. 
Federal & State-Level Stakeholder Outreach
We engage in conversations with stakeholders to spur the creation of research dollars for clinical psychedelic research studies. We host briefings, develop advocacy campaigns, provide policy analysis, create education tools, and engage in a consensus-driven approach to advance the psychedelic research space.
Amplifying Voices
Through nationwide outreach, legislative briefings, and public education, we share stories and voices that are often missing in psychedelic discourse.
Melissa
Melissa Lavasani is Founder and Chief Executive Officer of Washington, DC-based Psychedelic Medicine Coalition, a national association committed to creating and protecting access to psychedelic medicines through advocacy and education on a federal level. Inspired by her own experience of a working mother using psychedelics to heal her severe postpartum depression, Melissa championed Initiative 81, the Entheogenic Plant and Fungus Policy Act of 2020, which broke records as the largest ballot initiative win in Washington DC's history with 76% approval.

Through Psychedelic Medicine Coalition, Melissa educates lawmakers and advocates for policies that support research and safe, equitable access to psychedelics at the federal and state level. Melissa is also Founder and President of the Psychedelic Medicine Political Action Committee, a Founding Board Member of the Psychedelics and Healing Initiative at the Global Wellness Institute, and on the Advisory Boards of Drugs over Dinner and Universal Ibogaine.

Born in Washington, DC to Iranian immigrants, Melissa has a Bachelor’s degree in Economics from Macalester College, a Masters degree in Management from the University of Denver, and a Masters in Public Policy from George Mason University. As a devoted wife and mother, Melissa cherishes her free time, which she spends playing with her children, fly fishing, and showering love on her beloved pit bull, Gus. Melissa's bold leadership and unwavering commitment to this cause make her an inspiring force for change in the world.
Psychedelic Medicine Coalition is the only Washington, D.C.-based, nonpartisan advocacy organization dedicated to advancing the research, policy, and responsible implementation of psychedelic medicine in U.S. healthcare through federal and state advocacy.
We believe natural psychedelic medicines and their synthetic relatives hold vast potential as tools for improving the health and wellness of individuals and their communities.
Together, with our members, we foster pragmatic and diverse conversations at the local, state, and federal levels that seek to advance public policies that integrate psychedelic therapies into our societal frameworks.
With an emphasis on science and evidence-based research, our efforts are dramatically changing the way lawmakers view psychedelic medicines.

Be in the Know

Subscribe to our Newsletter
Sign up with your email address to receive weekly news and updates from Psychedelic Medicine Coalition.